Compare stocks

Euroapi S.A. operates in the pharmaceutical industry, specializing in the development, production, and marketing of active pharmaceutical ingredients (APIs). The company provides an extensive range of complex chemical molecules, including pain management and anesthetics, anti-infectives, and endocrine therapy solutions. Headquartered in Paris, France, Euroapi serves global markets, emphasizing high standards in quality and compliance. The company leverages long-standing expertise and technical capabilities, distinguishing itself with a broad product portfolio and investment in research and development to support innovation and meet diverse customer needs.

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio, while the 2026 acquisition of Apogee adds to AbbVie's immunology depth.